Beacon Pharmaceuticals Statistics

Total Valuation

DSE:BEACONPHAR has a market cap or net worth of BDT 28.60 billion. The enterprise value is 35.10 billion.

Market Cap	28.60B
Enterprise Value	35.10B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Oct 28, 2024

Share Statistics

DSE:BEACONPHAR has 231.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	231.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.87%
Owned by Institutions (%)	0.33%
Float	138.91M

Valuation Ratios

The trailing PE ratio is 50.17.

PE Ratio	50.17
Forward PE	n/a
PS Ratio	2.47
PB Ratio	4.39
P/TBV Ratio	4.40
P/FCF Ratio	18.87
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.89, with an EV/FCF ratio of 23.16.

EV / Earnings	61.58
EV / Sales	3.03
EV / EBITDA	12.89
EV / EBIT	16.02
EV / FCF	23.16

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 1.54.

Current Ratio	1.42
Quick Ratio	0.67
Debt / Equity	1.54
Debt / EBITDA	3.70
Debt / FCF	6.64
Interest Coverage	1.71

Financial Efficiency

Return on equity (ROE) is 8.88% and return on invested capital (ROIC) is 8.42%.

Return on Equity (ROE)	8.88%
Return on Assets (ROA)	7.28%
Return on Invested Capital (ROIC)	8.42%
Return on Capital Employed (ROCE)	21.54%
Revenue Per Employee	2.78M
Profits Per Employee	136,965
Employee Count	4,162
Asset Turnover	0.62
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.35% in the last 52 weeks. The beta is -0.37, so DSE:BEACONPHAR's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	-47.35%
50-Day Moving Average	128.86
200-Day Moving Average	141.47
Relative Strength Index (RSI)	41.09
Average Volume (20 Days)	175,524

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:BEACONPHAR had revenue of BDT 11.58 billion and earned 570.05 million in profits. Earnings per share was 2.47.

Revenue	11.58B
Gross Profit	5.97B
Operating Income	2.19B
Pretax Income	1.10B
Net Income	570.05M
EBITDA	2.72B
EBIT	2.19B
Earnings Per Share (EPS)	2.47

Full Income Statement

Balance Sheet

The company has 3.56 billion in cash and 10.07 billion in debt, giving a net cash position of -6.51 billion or -28.16 per share.

Cash & Cash Equivalents	3.56B
Total Debt	10.07B
Net Cash	-6.51B
Net Cash Per Share	-28.16
Equity (Book Value)	6.52B
Book Value Per Share	28.23
Working Capital	4.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.83 billion and capital expenditures -318.69 million, giving a free cash flow of 1.52 billion.

Operating Cash Flow	1.83B
Capital Expenditures	-318.69M
Free Cash Flow	1.52B
FCF Per Share	6.56

Full Cash Flow Statement

Margins

Gross margin is 51.56%, with operating and profit margins of 18.92% and 4.92%.

Gross Margin	51.56%
Operating Margin	18.92%
Pretax Margin	9.46%
Profit Margin	4.92%
EBITDA Margin	23.52%
EBIT Margin	18.92%
FCF Margin	13.09%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.62%.

Dividend Per Share	2.00
Dividend Yield	1.62%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	1
Payout Ratio	129.69%
Buyback Yield	n/a
Shareholder Yield	1.62%
Earnings Yield	1.99%
FCF Yield	5.30%

Dividend Details

Stock Splits

The last stock split was on November 27, 2011. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 27, 2011
Split Type	Forward
Split Ratio	1.05

Scores

DSE:BEACONPHAR has an Altman Z-Score of 3.18.

Altman Z-Score	3.18
Piotroski F-Score	n/a